• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头皮中重度斑块状银屑病患者头皮瘙痒数字评分量表的定性分析和可重复性评估。

Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.

机构信息

Celgene Corporation , Summit , NJ , USA.

Evidera , Bethesda , MD , USA.

出版信息

J Dermatolog Treat. 2019 Dec;30(8):775-783. doi: 10.1080/09546634.2019.1577546. Epub 2019 Mar 5.

DOI:10.1080/09546634.2019.1577546
PMID:30747550
Abstract

Pruritus is a prevalent and bothersome symptom of scalp psoriasis. Validated scales assessing scalp itch are needed to evaluate treatment efficacy. To evaluate comprehensibility and reproducibility of the Scalp Itch Numeric Rating Scale (NRS), a novel scale being used in a phase 3 study of apremilast. The Scalp Itch NRS, Modified Whole Body Itch NRS, Global Assessment of Psoriasis Severity-Scalp (GAPS-S), and Global Impression of Change-Scalp Itch (GIC-SI) were assessed among patients with moderate to severe scalp psoriasis. Convergent validity and test-retest reliability between two visits (7 ± 3 days apart) were assessed using intra-class and Spearman's correlations. Patients found the Scalp Itch NRS easy to use and understand. Convergent validity (Modified Whole Body Itch NRS Visit 1:  = 0.71, Visit 2:  = 0.92, < .0001; GAPS-S Visit 1:  = 0.62, Visit 2:  = 0.63, < .0001), and consistency with changes (Modified Whole Body Itch NRS:  = 0.69, < .0001; GAPS-S:  = 0.42,  = .0029) were demonstrated. The Scalp Itch NRS showed strong test-retest reliability (intra-class correlation coefficient = 0.87;  = 0.89). Change scores on the Scalp Itch NRS were consistent with change scores on the GIC-SI. The Scalp Itch NRS is a valid and reproducible measure of scalp itch in patients with moderate to severe scalp psoriasis. NCT03123471.

摘要

瘙痒是头皮银屑病的一种常见且令人困扰的症状。需要经过验证的头皮瘙痒评估量表来评估治疗效果。为了评估阿普米司特 3 期研究中使用的新型头皮瘙痒数字评分量表(NRS)的可理解性和可重复性。评估了中重度头皮银屑病患者的头皮瘙痒 NRS、改良全身瘙痒 NRS、头皮严重程度整体评估(GAPS-S)和头皮瘙痒整体变化印象(GIC-SI)。使用 ICC 和 Spearman 相关系数评估两次就诊(间隔 7 ± 3 天)之间的收敛效度和重测信度。患者认为头皮瘙痒 NRS 易于使用和理解。收敛效度(改良全身瘙痒 NRS 第 1 次就诊:  = 0.71,第 2 次就诊:  = 0.92,< 0.0001;GAPS-S 第 1 次就诊:  = 0.62,第 2 次就诊:  = 0.63,< 0.0001),以及与变化的一致性(改良全身瘙痒 NRS:  = 0.69,< 0.0001;GAPS-S:  = 0.42,  = 0.0029)得到了证明。头皮瘙痒 NRS 具有很强的重测信度(ICC  = 0.87;  = 0.89)。头皮瘙痒 NRS 的评分变化与 GIC-SI 的评分变化一致。头皮瘙痒 NRS 是一种有效的、可重复的中重度头皮银屑病患者头皮瘙痒评估工具。NCT03123471。

相似文献

1
Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.头皮中重度斑块状银屑病患者头皮瘙痒数字评分量表的定性分析和可重复性评估。
J Dermatolog Treat. 2019 Dec;30(8):775-783. doi: 10.1080/09546634.2019.1577546. Epub 2019 Mar 5.
2
Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.中重度斑块状银屑病患者瘙痒数字评分量表的心理测量特性。
Br J Dermatol. 2016 Jul;175(1):157-62. doi: 10.1111/bjd.14464. Epub 2016 May 8.
3
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.验证瘙痒数字评定量表在结节性痒疹相关瘙痒中的心理测量特性:一项随机临床试验的二次分析。
JAMA Dermatol. 2020 Dec 1;156(12):1354-1358. doi: 10.1001/jamadermatol.2020.3071.
4
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.瘙痒峰值数字评定量表:评估中重度特应性皮炎瘙痒的心理测量验证和应答者定义。
Br J Dermatol. 2019 Oct;181(4):761-769. doi: 10.1111/bjd.17744. Epub 2019 May 1.
5
Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.中重度特应性皮炎成人患者中瘙痒数字评分量表、皮肤疼痛数字评分量表和特应性皮炎睡眠量表的心理测量特性。
Health Qual Life Outcomes. 2021 Oct 23;19(1):247. doi: 10.1186/s12955-021-01877-8.
6
The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis.用于中度至重度斑块状银屑病或银屑病关节炎患者的最严重瘙痒数字评定量表。
Int J Dermatol. 2015 Jun;54(6):715-22. doi: 10.1111/ijd.12645. Epub 2014 Dec 16.
7
Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study.阿普米司特治疗中重度头皮斑块状银屑病的疗效和安全性:一项 3b 期、多中心、随机、安慰剂对照、双盲研究的结果。
J Am Acad Dermatol. 2020 Jul;83(1):96-103. doi: 10.1016/j.jaad.2020.01.072. Epub 2020 Feb 4.
8
Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials.结节性痒疹最差瘙痒数字评定量表:两项随机临床试验的二次分析。
JAMA Dermatol. 2024 Aug 1;160(8):813-821. doi: 10.1001/jamadermatol.2024.1634.
9
The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale.银屑病患儿的瘙痒体验:瘙痒数字评定量表的质性探索
Pediatr Dermatol. 2021 Mar;38(2):405-412. doi: 10.1111/pde.14403. Epub 2020 Dec 18.
10
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.罗氟司特乳膏(ARQ-151)对慢性斑块状银屑病成人瘙痒和瘙痒相关睡眠缺失的影响:一项 2b 期试验的患者报告瘙痒结局。
Am J Clin Dermatol. 2023 Mar;24(2):305-313. doi: 10.1007/s40257-022-00739-3. Epub 2022 Nov 12.

引用本文的文献

1
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial.古塞库单抗用于治疗所有肤色的中度至重度头皮银屑病:VISIBLE随机临床试验的队列B
JAMA Dermatol. 2025 Jun 25. doi: 10.1001/jamadermatol.2025.1849.
2
PDE4 inhibitors in psoriasis therapy: current insights and future directions.银屑病治疗中的磷酸二酯酶4抑制剂:当前见解与未来方向
Inflammopharmacology. 2025 May 15. doi: 10.1007/s10787-025-01778-y.
3
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
0.3% 罗氟司特泡沫剂用于头皮和身体银屑病:ARRECTOR 3期随机临床试验
JAMA Dermatol. 2025 May 7. doi: 10.1001/jamadermatol.2025.1136.
4
Impact of a dermatological rehabilitation program on cardiovascular risks of psoriasis patients.皮肤病康复计划对银屑病患者心血管风险的影响。
J Dtsch Dermatol Ges. 2025 Feb;23(2):161-171. doi: 10.1111/ddg.15585. Epub 2024 Nov 13.
5
Validation of the Peak Pruritus-Numerical Rating Scale in patients with chronic plaque psoriasis: results from a phase 2 study.验证斑块状银屑病患者的瘙痒峰值数字评分量表:一项 2 期研究的结果。
Int J Dermatol. 2024 Dec;63(12):e375-e382. doi: 10.1111/ijd.17428. Epub 2024 Aug 19.